Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.38 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 08/7/15 All times are local (Market data is delayed by at least 15 minutes).

panacea global inc (PANG) Snapshot

Previous Close
Day High
Day Low
52 Week High
12/11/14 - $0.55
52 Week Low
12/1/14 - $0.0030
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for PANACEA GLOBAL INC (PANG)

Related News

No related news articles were found.

panacea global inc (PANG) Related Businessweek News

No Related Businessweek News Found

panacea global inc (PANG) Details

Panacea Global, Inc., a development stage biopharmaceutical company, focuses on the provision of blood, serum, and tissue tests to diagnose and monitor cancer. The company, through a license agreement with Panacea Pharmaceuticals, Inc., sells early detection cancer tests. It focuses on the development of novel proteins and biochemical pathways related to cellular regulation and cell cycle abnormalities in oncology diseases. The company’s blood and serum tests include BC Detect, an in vitro serum test to detect and identify recurrence of breast cancer; CC Detect, an in vitro serum test to detect and identify recurrence of colorectal cancer; LC Detect, an in vitro serum test to detect and identify recurrence of lung cancer; PC Detect, an in vitro serum test to detect and identify recurrence of prostate cancer; and TK Sense, a RT-PCR test that predicts the response of patients with chronic myelogenous leukemia to the drug imatinib. Panacea Global, Inc. is based in Richmond Hill, Canada.

3 Employees
Last Reported Date: 03/31/14

panacea global inc (PANG) Top Compensated Officers

Chief Executive Officer, President, Chief Fin...
Total Annual Compensation: --
Vice President, Secretary and Director
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

panacea global inc (PANG) Key Developments

Panacea Global, Inc. announced delayed annual 10-K filing

On 03/31/2015, Panacea Global, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

Panacea Global, Inc. Enters into Distributor Agreement with Panacea Avecina, Inc

On January 23, 2015, a subsidiary of Panacea Global, Inc. entered into a Distributor Agreement with Panacea Avecina, Inc. Avecina agreed to distribute the cancer testing products based on human aspartyl beta-hydroxylase of the company's Ontario-chartered subsidiary, Panacea Global, Inc., in the countries of Bahrain, Iran, Iraq, Jordan, Oman, and Yemen. Avecina will pay $70 per product to Panacea Ontario with a goal of purchasing and distributing $500,000 worth of products by December 31, 2015.

Panacea Global, Inc. Announces Auditor Changes

On September 5, 2014, the Board of Directors of Panacea Global, Inc. dismissed EFP Rotenberg, LLP as its independent registered public accounting firm. On September 5, 2014, the Board of Directors of the company engaged GBH CPAs, PC as its independent registered public accounting firm.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PANG:US $0.38 USD 0.00

PANG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PANG.
View Industry Companies

Industry Analysis


Industry Average

Valuation PANG Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 0.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PANACEA GLOBAL INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at